Skip to main content

Verition Fund Management LLC

Position in BNTX — BioNTech SE

CIK 1454027 GREENWICH, CT

Position in BNTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$433,426
-$22,172 QoQ
Shares Held
4,658
-9.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#155
of 282 holders
Holding Since
Dec 2020
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BNTX Over Time

Shares Held

Position Value (USD)

Derivatives in BNTX

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$837,450
PutShares
9,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Verition Fund Management LLC holds $152,220,097 across 64 Biotechnology names. BNTX ranks #46 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BNTX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $433,426 4,658
2026-06-30 $837,450 9,000
2026-03-31 $799,920 9,000
2026-03-31 $455,598 5,126
2025-12-31 $437,920 4,600
2025-12-31 $713,048 7,490
2025-12-31 $1,294,720 13,600
2025-09-30 $2,820,532 28,600
2025-09-30 $1,197,444 12,142
2025-09-30 $1,913,228 19,400
2025-06-30 $851,760 8,000
2025-06-30 $883,701 8,300
2024-12-31 $1,931,566 16,951
2021-12-31 $230,473 894
2020-12-31 $526,293 6,456